Lindsey Surace, MD
Gastroenterology · Harrisburg, PANPI 1346412673
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $6,700 of the $8,327 with a category attached, or 80.5%. AbbVie accounts for 84.0% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2019 at $7,626 and has fallen 98.4% since, to $125 in 2024.
Across 85 payments — averaging $97.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$7K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$395
- Pfizer$242
- Gilead$188
- Janssen Scientific Affairs, LLC$118
- Foundation Medicine, Inc.$118
- plus $268 from 7 others
Across 126 payments — averaging $2262.09 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$112K
- Roche Products Limited$71K
- Pfizer$66K
- Takeda Pharmaceuticals U.S.A., Inc.$23K
- Genentech, Inc.$11K
- AbbVie$1K
What the payments were for
- Speaking & faculty fees$6,70080%
- Travel & lodging$1031%
- Food & beverage$1,52418%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 25 | $6,998 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 38 | $395 |
| Pfizer | 6 | $242 |
| Gilead | 5 | $188 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Foundation Medicine, Inc. | 1 | $118 |
| Boston Scientific | 1 | $93 |
| Genentech, Inc. | 1 | $60 |
| Fujifilm Healthcare Americas Corporation | 1 | $43 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $33 |
| UCB, Inc. | 1 | $18 |
| Ferring Pharmaceuticals Inc. | 1 | $14 |
| Johnson & Johnson | 1 | $7 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ZENPEP$3,500
- VIBERZI$2,800
- LINZESS$1,800
- VELSIPITY$125
- STELARA$118
- FOUNDATIONONE$118
- FOUNDATIONONE HEME$118
- FOUNDATIONONE CDX$118
- FOUNDATIONFOCUS$118
- FOUNDATIONONE LIQUID$118
How this compares
$8,327 in reported general payments places this provider in the 75th percentile of 935 gastroenterology providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 14 | $43 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Harrisburg
- Miguel RegueiroPittsburgh$1.5M
- Adam PeytonAllentown$985K
- Shahin RahimianWaynesboro$592K
- Sandra El-HachemPittsburgh$472K
- Harshit KharaDanville$438K
- Kofi ClarkeHershey$426K
- Michael KochmanPhiladelphia$361K
- Gary LichtensteinPhiladelphia$342K
- Elie AounPittsburgh$323K
- Andrew TinsleyHershey$322K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.